This page has been fact checked by an experienced mesothelioma Patient Advocate. Sources of information are listed at the bottom of the article.
We make every attempt to keep our information accurate and up-to-date.
Please Contact Us with any questions or comments.
Dr. Bostock Rosenzweig is a thoracic surgeon at the Hollings Cancer Center and MUSC Health. His practice is focused on patients with lung and esophageal cancer, malignant pleural mesothelioma, mediastinal and chest wall tumors, and benign esophageal diseases including reflux, achalasia, and paraesophageal hernias. Additionally, he cares for end-stage lung disease as part of the multidisciplinary lung transplant team. He has special interests in health disparities, shared decision-making, esophageal cancer, minimally invasive thoracic surgery, and robotic surgery.
Education and Career
Dr. Bostock earned his medical degree, as well as a Master’s degree in Science and Clinical Investigation, at Anáhuac University Medical School in Mexico City, Mexico. From there, he moved on to pursue an internship at Brigham and Women’s Hospital and then completed General Surgery training at Dartmouth-Hitchcock Medical Center, where he was recognized by the students of Geisel School of Medicine for excellence in medical education with the Thomas P. Almy Housestaff Teaching Award and the Gold Foundation Humanism and Excellence in Teaching Award. He also completed a fellowship in Thoracic Surgery at the University of Texas MD Anderson Cancer Center.
He has received several awards for his research in cardiovascular and thoracic surgery and has authored more than thirty peer-reviewed articles, seven abstracts, and nine book chapters. He has also presented at more than twenty-five academic meetings across the United States.
His recent articles include:
Defining Pathologic Upstaging in cT1b Esophageal Cancer: Should We Consider Neoadjuvant Therapy? Nov 2023, David R Mann, Kathryn E Engelhardt, Barry Gibney, Ian Christopher Bostock
Surgical Perspective on the American Thoracic Society Statement on Race Correction of Pulmonary Function Testing, Aug 2023, David Cooke, Sidra Bonner, Ian Christopher Bostock, Cherie P. Erkmen
Mentorship and support for the Latino surgical community: where are we now? Nov 2022, Ian Christopher Bostock, Minerva A Romero Arenas, Mara B Antonoff.
Risk of recipient age on 1‐year mortality after simultaneous heart-lung transplantation, Oct 2022. Jennie H. Kwon, William A. Hardy, Khaled Shorbaji, Arman Kilic.
The Impact of Recipient Age on Outcomes of Simultaneous Heart-Lung Transplantation, Apr 2022, J.H. Kwon, K. Shorbaji, Lauren Huckaby, Ahmet Kilic.
Reply: Preventing Atrio-Esophageal Fistula: a Dish Best Served Cold, Apr 2022, Barry Gibney, Ian Christopher Bostock
Social Disparities in Thoracic Surgery Database Research, Feb 2022, Kyle G. Mitchell, Ian Christopher Bostock, Mara B Antonoff.
Letter to the Editor: Mentorship Is Necessary but Not Sufficient to Promote Diversity in Surgery, Jan 2022, Hope A. Feldman, Ian Christopher Bostock, Alexis P. Chidi, Mara B Antonoff.
Prolonged neutrophilia is associated with worse outcomes after Esophagectomy, Dec 2021, Ian Christopher Bostock, Nicolas Zhou, Mara B Antonoff.
Barriers to surveillance imaging adherence in early-stage lung cancer, Dec 2021, Ian Christopher Bostock, Wayne Hofstetter, Reza Mehran, Mara B Antonoff.
Barriers to Parental Leave During Training: Time for Change, Jul 2021, Ian Christopher Bostock, Erin M. Bayley, Mara B Antonoff.
Challenging Dogmas to Enable Progress Forward, May 2021, Ian Christopher Bostock, Mara B AntonoffGet Your FREE Mesothelioma Packet
Written by Terri Oppenheimer
Terri Oppenheimer has been writing about mesothelioma and asbestos topics for over ten years. She has a degree in English from the College of William and Mary. Terri’s experience as the head writer of our Mesothelioma.net news blog gives her a wealth of knowledge which she brings to all Mesothelioma.net articles she authors.
Page Edited by Patient Advocate Dave Foster
Dave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.